Comparative Effectiveness of nab-Paclitaxel Plus Gemcitabine vs FOLFIRINOX in Metastatic Pancreatic Cancer: A Retrospective Nationwide Chart Review in the United States

被引：0
|
作者：
Sunnie Kim
James E. Signorovitch
Hongbo Yang
Oscar Patterson-Lomba
Cheryl Q. Xiang
Brian Ung
Monika Parisi
John L. Marshall
机构：
[1] MedStar Georgetown University Hospital,Ruesch Center for the Cure of GI Cancers
[2] Analysis Group,undefined
[3] Inc.,undefined
[4] Celgene Corporation,undefined
[5] Georgetown University,undefined
[6] Lombardi Comprehensive Cancer Center,undefined
来源：
Advances in Therapy | 2018年 / 35卷
关键词：
Adverse events; FOLFIRINOX; Metastatic adenocarcinoma of the pancreas; nab-Paclitaxel; Real-world evidence; Survival analysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1564 / 1577
页数：13
相关论文
共 50 条
  • [1] Comparative Effectiveness of nab-Paclitaxel Plus Gemcitabine vs FOLFIRINOX in Metastatic Pancreatic Cancer: A Retrospective Nationwide Chart Review in the United States
    Kim, Sunnie
    Signorovitch, James E.
    Yang, Hongbo
    Patterson-Lomba, Oscar
    Xiang, Cheryl Q.
    Ung, Brian
    Parisi, Monika
    Marshall, John L.
    ADVANCES IN THERAPY, 2018, 35 (10) : 1564 - 1577
  • [2] Comparative effectiveness of nab-paclitaxel plus gemcitabine versus FOLFIRINOX in metastatic pancreatic cancer: A nationwide chart review in the United States.
    Kim, Sunnie S.
    Signorovitch, James
    Yang, Hongbo
    Patterson-Lomba, Oscar
    Xiang, Cheryl
    Ung, Brian
    Parisi, Monika
    Marshall, John
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [3] Comparative effectiveness of gemcitabine vs gemcitabine plus nab-paclitaxel vs FOLFIRINOX for unresectable pancreatic cancer
    Yamamoto, Shun
    Ueno, Hideki
    Tanaka, Midori
    Inagaki, Yuji
    Ohba, Akihiro
    Sakamoto, Yasunari
    Kondo, Shunsuke
    Morizane, Chigusa
    Okusaka, Takuji
    ANNALS OF ONCOLOGY, 2017, 28
  • [4] Comparison of gemcitabine plus nab-paclitaxel and FOLFIRINOX in metastatic pancreatic cancer
    Han, Sung Yong
    Kim, Dong Uk
    Seol, Young Mi
    Kim, Suk
    Lee, Nam Kyung
    Hong, Seung Baek
    Seo, Hyung-Il
    WORLD JOURNAL OF CLINICAL CASES, 2020, 8 (17) : 3718 - 3729
  • [5] Comparison of gemcitabine plus nab-paclitaxel and FOLFIRINOX in metastatic pancreatic cancer
    Sung Yong Han
    Dong Uk Kim
    Young Mi Seol
    Suk Kim
    Nam Kyung Lee
    Seung Baek Hong
    Hyung-Il Seo
    World Journal of Clinical Cases, 2020, (17) : 3718 - 3729
  • [6] Retrospective analysis of institutional outcomes with FOLFIRINOX versus nab-paclitaxel plus gemcitabine in metastatic pancreatic cancer
    Singh, Amisha
    Shroff, Rachna T.
    McBride, Ali
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [7] A multicenter retrospective study of gemcitabine plus nab-paclitaxel or FOLFIRINOX in metastatic pancreatic cancer: NAPOLEON study
    Nakazawa, J.
    Otsuka, T.
    Shimokawa, M.
    Koga, F.
    Ueda, Y.
    Otsu, S.
    Arima, S.
    Fukahori, M.
    Makiyama, A.
    Taguchi, H.
    Honda, T.
    Shibuki, T.
    Shirakawa, T.
    Mitsugi, K.
    Nio, K.
    Ide, Y.
    Ureshino, N.
    ANNALS OF ONCOLOGY, 2019, 30
  • [8] Gemcitabine plus nab-paclitaxel vs. FOLFIRINOX for patients with advanced pancreatic cancer
    Junko Tahara
    Kyoko Shimizu
    Nao Otsuka
    Junichi Akao
    Yukiko Takayama
    Katsutoshi Tokushige
    Cancer Chemotherapy and Pharmacology, 2018, 82 : 245 - 250
  • [9] Gemcitabine plus nab-paclitaxel vs. FOLFIRINOX for patients with advanced pancreatic cancer
    Tahara, Junko
    Shimizu, Kyoko
    Otsuka, Nao
    Akao, Junichi
    Takayama, Yukiko
    Tokushige, Katsutoshi
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2018, 82 (02) : 245 - 250
  • [10] Comparative effectiveness of FOLFIRINOX or nab-paclitaxel plus gemcitabine in locally advanced or metastatic pancreatic cancer: A population-based analysis
    Wang, Ying
    Chen, Leo
    Camateros, Pierre
    Gill, Sharlene
    Renouf, Daniel John
    Cheung, Winson Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
12345